MISTY WHEELOCK: Open Payments
NPI 1073700217 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 71 payments from 30 companies in 2025. Trend: 2023 $1,401 · 2024 $1,136 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $149 |
| ABBVIE INC. | 5 | $115 |
| Janssen Biotech, Inc. | 5 | $110 |
| Genentech USA, Inc. | 4 | $104 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Incyte Corporation | 4 | $72 |
| Eisai Inc. | 3 | $67 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $60 |
Products named: KISQALI, KEYTRUDA, DARZALEX, LIBTAYO, Lenvima, ENJAYMO, Tecentriq, ICLUSIG.
Industry payments across MO — which companies pay providers there.
